Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Brixton Biosciences Inc
Profile last edited on: 3/2/2023      CAGE: 8WGJ3      UEI: GAPRGK1TWAJ4

Business Identifier: Developing novel device-based solutions for pain management
Year Founded
2018
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1 Mifflin Place Suite 320
Cambridge, MA 02138
   (617) 290-3348
   info@brixtonbio.com
   www.brixtonbio.com
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

Developer of a life science product based in Cambridge, United States. The company is currently operating in stealth mode.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$252,130
Phase II Dollars
$0
Total Awarded
$252,130

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2022 1 NIH $252,130
Project Title: Injectable Ice Slurry Cooling Technology for Treatment of Postoperative Pain

Key People / Management

  Sameer A Sabir -- Co-Founder & CEO

  Tasneem Dohadwala -- Director

  Robert Forrester -- Director

  Lilit Garibyan -- Director

  Paul Hayre -- Advisor

  Olivier Kagan -- VP Operations

  Bill Mccullen -- Director

  Joshua Phillips -- Director

  Robert Pozen -- Director

  Charles Sidoti -- Head of Product Development

  Josh Tolkoff -- Director

Company News

There are no news available.